Īpaši bīstamu kandidātu saraksta vielu saraksts licencēšanai
Īpaši bīstamu kandidātu saraksta vielu saraksts licencēšanai
(publicēts saskaņā ar REACH regulas 59. panta 10. punktu)
Īpaši bīstamu kandidātu saraksta vielu saraksts licencēšanai
Piezīmes:
- Autentiskā versija: Par autentisku uzskata tikai kandidātu sarakstu, kas publicēts šajā tīmekļa vietnē. Pēc vielas iekļaušanas kandidātu sarakstā šajā tīmekļa vietnē uz uzņēmumiem var tūlīt attiekties juridiskas saistības, kā arī jo īpaši REACH regulas 7., 31. un 33. pants.
- Skaitliskie identifikatori: Katrs kandidātu saraksta ieraksts attiecas uz vielas bezūdens un hidratēto formu. Ierakstā parādītais CAS numurs parasti attiecas uz bezūdens formu. Ieraksta joma attiecas arī uz vielas hidratētām formām, kas identificētas ar citiem CAS numuriem.
- Citi skaitliskie identifikatori: Ierakstiem ar “-” EK numuru un CAS numuru slejās ir iekļauts neizsmeļošs EK un/vai CAS reģistra numuru saraksts, kurā sniegts to vielu vai vielu grupu apraksts, uz kurām attiecas Kandidātu saraksta ierakstu joma, ja tas ir praktiski iespējams. Informācijai var piekļūt ar izvēlētā ieraksta Details [Sīkākas informācijas] taustiņu.
Filter the list
The List does not contain any Substances.
Lēmums | IUCLID dataset | ||||||
---|---|---|---|---|---|---|---|
show/hide
(±)-1,7,7-trimethyl-3-[(4-methylphenyl)methylene]bicyclo[2.2.1]heptan-2-one
EK Nr.:
253-242-6
| CAS Nr.:
36861-47-9
(3E)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
EK Nr.:
-
| CAS Nr.:
1782069-81-1
(1R,3E,4S)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
EK Nr.:
-
| CAS Nr.:
95342-41-9
(1S,3E,4R)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
EK Nr.:
-
| CAS Nr.:
852541-30-1
(1R,3Z,4S)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
EK Nr.:
-
| CAS Nr.:
852541-21-0
(1R,4S)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
EK Nr.:
-
| CAS Nr.:
741687-98-9
(1S,3Z,4R)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
EK Nr.:
-
| CAS Nr.:
852541-25-4
|
-
|
-
|
17-janv.-2022
|
Endocrine disrupting properties (Article 57(f) - human health) |
Details | ||
203-794-9
|
110-71-4
|
18-jūn.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
253-692-3
|
37853-59-1
|
17-janv.-2023
|
vPvB (Article 57e) |
Details | |||
202-486-1
|
96-18-4
|
20-jūn.-2011
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
with ≥ 0.3% of dihexyl phthalate (EC No. 201-559-5)
show/hide
1,2-Benzenedicarboxylic acid, mixed decyl and hexyl and octyl diesters
EK Nr.:
272-013-1
| CAS Nr.:
68648-93-1
|
-
|
-
|
15-jūn.-2015
|
Toxic for reproduction (Article 57c) |
Details | ||
276-158-1
|
71888-89-6
|
20-jūn.-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
271-084-6
|
68515-42-4
|
20-jūn.-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
271-093-5
|
68515-50-4
|
16-jūn.-2014
|
Toxic for reproduction (Article 57c) |
Details | |||
284-032-2
|
84777-06-0
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
203-977-3
|
112-49-2
|
18-jūn.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
203-458-1
|
107-06-2
|
19-dec.-2011
|
Carcinogenic (Article 57a) |
Details | |||
211-076-1
|
629-14-1
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
219-514-3
|
2451-62-9
|
18-jūn.-2012
|
Mutagenic (Article 57b) |
Details | |||
-
|
423-400-0
|
59653-74-6
|
18-jūn.-2012
|
Mutagenic (Article 57b) |
Details | ||
214-317-9
|
1120-71-4
|
17-dec.-2015
|
Carcinogenic (Article 57a) |
Details | |||
204-661-8
|
123-91-1
|
08-jūl.-2021
|
Carcinogenic (Article 57a) Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
Details | |||
covering any of its individual anti- and syn-isomers or any combination thereof
show/hide
(1S,2S,5R,6R,9S,10S,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene
EK Nr.:
-
| CAS Nr.:
135821-03-3
(1S,2S,5S,6S,9R,10R,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene
EK Nr.:
-
| CAS Nr.:
135821-74-8
1,6,7,8,9,14,15,16,17,17,18,18-dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene
EK Nr.:
236-948-9
| CAS Nr.:
13560-89-9
|
-
|
-
|
15-janv.-2018
|
vPvB (Article 57e) |
Details | ||
3-benzylidene camphor; 3-BC
|
239-139-9
|
15087-24-8
|
15-janv.-2019
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
203-445-0
|
106-94-5
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
212-828-1
|
872-50-4
|
20-jūn.-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
214-012-0
|
1072-63-5
|
25-jūn.-2020
|
Toxic for reproduction (Article 57c) |
Details | |||
201-236-9
|
79-94-7
|
17-janv.-2023
|
Carcinogenic (Article 57a) |
Details | |||
202-918-9
|
101-14-4
|
19-dec.-2011
|
Carcinogenic (Article 57a) |
Details | |||
AP-5
|
401-720-1
|
6807-17-6
|
15-janv.-2019
|
Toxic for reproduction (Article 57c) |
Details | ||
show/hide
|
-
|
-
|
08-jūl.-2021
|
Carcinogenic (Article 57a) |
Details | ||
covering any of their individual isomers and combinations thereof
show/hide
potassium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propionate
EK Nr.:
266-578-3
| CAS Nr.:
67118-55-2
|
-
|
-
|
16-jūl.-2019
|
Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
Details | ||
211-989-5
|
732-26-3
|
23-janv.-2024
|
Toxic for reproduction (Article 57c) PBT (Article 57d) |
Details | |||
223-383-8
|
3864-99-1
|
17-dec.-2015
|
vPvB (Article 57e) |
Details | |||
204-450-0
|
121-14-2
|
13-janv.-2010
|
Carcinogenic (Article 57a) |
Details | |||
247-384-8
|
25973-55-1
|
17-dec.-2014
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
221-573-5
|
3147-75-9
|
23-janv.-2024
|
vPvB (Article 57e) |
Details | |||
253-037-1
|
36437-37-3
|
17-dec.-2015
|
vPvB (Article 57e) |
Details | |||
show/hide
|
-
|
-
|
08-jūl.-2021
|
Toxic for reproduction (Article 57c) |
Details | ||
438-340-0
|
119344-86-4
|
23-janv.-2024
|
Toxic for reproduction (Article 57c) |
Details | |||
223-346-6
|
3846-71-7
|
17-dec.-2014
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
CG 25-369; IRGACURE 369; TK 11-319
|
404-360-3
|
119313-12-1
|
16-janv.-2020
|
Toxic for reproduction (Article 57c) |
Details | ||
203-804-1
|
110-80-5
|
15-dec.-2010
|
Toxic for reproduction (Article 57c) |
Details | |||
203-839-2
|
111-15-9
|
20-jūn.-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
239-622-4
|
15571-58-1
|
17-dec.-2014
|
Toxic for reproduction (Article 57c) |
Details | |||
201-963-1
|
90-04-0
|
19-dec.-2011
|
Carcinogenic (Article 57a) |
Details | |||
203-713-7
|
109-86-4
|
15-dec.-2010
|
Toxic for reproduction (Article 57c) |
Details | |||
203-772-9
|
110-49-6
|
16-jūl.-2019
|
Toxic for reproduction (Article 57c) |
Details | |||
ACETOCURE 97; GENOCURE*PMP; IGM 4817; IRGACURE 907; SPEEDCURE 97
|
400-600-6
|
71868-10-5
|
16-janv.-2020
|
Toxic for reproduction (Article 57c) |
Details | ||
211-765-7
|
693-98-1
|
25-jūn.-2020
|
Toxic for reproduction (Article 57c) |
Details | |||
ZOLDINE MS-PLUS
|
421-150-7
|
143860-04-2
|
19-dec.-2012
|
Toxic for reproduction (Article 57c) |
Details | ||
202-974-4
|
101-77-9
|
28-okt.-2008
|
Carcinogenic (Article 57a) |
Details | |||
201-025-1
|
77-40-7
|
08-jūl.-2021
|
Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
with ≥ 0.1% of Michler's ketone (EC No. 202-027-5) or Michler's base (EC No. 202-959-2)
|
209-218-2
|
561-41-1
|
18-jūn.-2012
|
Carcinogenic (Article 57a) |
Details | ||
202-027-5
|
90-94-8
|
18-jūn.-2012
|
Carcinogenic (Article 57a) |
Details | |||
Bisphenol A; BPA
|
201-245-8
|
80-05-7
|
12-janv.-2017
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | ||